for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Heron Therapeutics provides update on FDA review of SUSTOL NDA

April 18 (Reuters) - Heron Therapeutics Inc :

* Heron Therapeutics provides update on FDA review of Sustol NDA

* FDA has indicated that there are no substantive deficiencies in NDA for Sustol injection

* FDA has begun labeling discussions with company Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up